Disease characterization using LQTS-specific induced pluripotent stem cells
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
AIMS: Long QT syndrome (LQTS) is an inheritable and life-threatening disease; however, it is often difficult to determine disease characteristics in sporadic cases with novel mutations, and more precise analysis is necessary for the successful development of evidence-based clinical therapies. This study thus sought to better characterize ion channel cardiac disorders using induced pluripotent stem cells (iPSCs). METHODS AND RESULTS: We reprogrammed somatic cells from a patient with sporadic LQTS and from controls, and differentiated them into cardiomyocytes through embryoid body (EB) formation. Electrophysiological analysis of the LQTS-iPSC-derived EBs using a multi-electrode array (MEA) system revealed a markedly prolonged field potential duration (FPD). The IKr blocker E4031 significantly prolonged FPD in control- and LQTS-iPSC-derived EBs and induced frequent severe arrhythmia only in LQTS-iPSC-derived EBs. The IKs blocker chromanol 293B did not prolong FPD in the LQTS-iPSC-derived EBs, but significantly prolonged FPD in the control EBs, suggesting the involvement of IKs disturbance in the patient. Patch-clamp analysis and immunostaining confirmed a dominant-negative role for 1893delC in IKs channels due to a trafficking deficiency in iPSC-derived cardiomyocytes and human embryonic kidney (HEK) cells. CONCLUSIONS: This study demonstrated that iPSCs could be useful to characterize LQTS disease as well as drug responses in the LQTS patient with a novel mutation. Such analyses may in turn lead to future progress in personalized medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [6]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Human-induced pluripotent stem cells (hiPSCs) have become a promising tool for analysing human genetic diseases.(8,9) Many studies have already shown that apparent cellular phenotypes of familial genetic disorders are recapitulated by disease-specific iPSC-derived cells in vitro.”
BackgroundZipes, D. P., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.21.2334 · Cited by 2,744
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,466
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251 · cited 1×
“However, most patients for generating iPSCs in previous reports were already diagnosed with responsible genes and/or had familial history.(10) –13,31,32 We showed here that iPSCs can recapitulate the phenotype of a sporadic patient with LQTS type1.”
BackgroundZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
Cited by
Items 101–177 of 177
Friedrichs, S., Malan, D., Voß, Y., & Sasse, P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010102 · Cited by 16
“Furthermore, other groups have successfully generated iPS cells from LQTS 1, 2 and 3 patients, and the cardiomyocytes differentiated from these cells recapitulated the typical characteristics of the respective disease [6–11].”
BackgroundMicheu, M. M., & Rosca, A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i4.281 · Cited by 17
Okata, S., Yuasa, S., Yamane, T., Furukawa, T., & Fukuda, K. (2013) · PubMed · Cited by 13
Nishimura, M., Ueda, M., Ebata, R., Utsuno, E., Ishii, T., Matsushita, K., Ohara, O., Shimojo, N., Kobayashi, Y., & Nomura, F. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0430-7 · Cited by 13
“In the absence of corresponding animal models, iPS cell technology [31] has enabled the study of cell biology with gene variants.”
BackgroundThe Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity
Kistamás, K., Lamberto, F., Vaičiulevičiūtė, R., Leal, F., Muenthaisong, S., Marte, L., Subías-Beltrán, P., Alaburda, A., Arvanitis, D. N., Zana, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179186 · Cited by 13
“The main responses to ischaemic conditions consist of reduced cell viability, contractility (reduced beating frequency, increased depolarisation time, and field potential propagation), and reduced sarcomere coverage and nuclear size, representing myocardium damage and arrhythmias in vivo [237–239].”
BackgroundPerspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research
Goedel, A., My, I., Sinnecker, D., & Moretti, A. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0828-z · Cited by 13
Zheng, Z., & Jiangfang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.687007 · Cited by 11
“Dysfunctional mutation of the hERG gene causes haplotype deficiency or dominant-negative effects in its protein expression, which can partially or completely reduce the IKr current and thus prolong the repolarization time course (Egashira et al., 2012; Zhang et al., 2014; Cubeddu, 2016; Ono et al., 2020).”
BackgroundŠarić, T., Halbach, M., Khalil, M., & Er, F. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.863275 · Cited by 14
Egashira, T., Yuasa, S., Tohyama, S., Kuroda, Y., Suzuki, T., Seki, T., & Fukuda, K. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_165 · Cited by 10
Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 11
“[90] P631fs/33) Dermal fibroblasts Retrovirus Embryoid body ● Reduced IKs density via dominantnegative trafficking.”
BackgroundPluripotent Stem Cells as a Platform for Cardiac Arrhythmia Drug Screening
Leyton-Mange, J. S., & Milan, D. J. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0334-1 · Cited by 10
iPCS Cell Modeling of Inherited Cardiac Arrhythmias
Shinnawi, R., & Gepstein, L. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0331-4 · Cited by 11
Future Treatment of Heart Failure Using Human iPSC-Derived Cardiomyocytes
Tohyama, S., & Fukuda, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-54628-3_4 · Cited by 9
Wegener, M., Bader, A., & Giri, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.010 · Cited by 8
Gao, Q., WANG, P. H., Qiu, H., Qiu, B., Yi, W., Tu, W., Lin, B., Sun, D., Zeng, R., Huang, M., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.031 · Cited by 9
The genetics of pro‐arrhythmic adverse drug reactions
Petropoulou, E., Jamshidi, Y., & Behr, E. R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12208 · Cited by 10
Human iPS cell models of Jervell and Lange-Nielsen syndrome
Bellin, M., & Greber, B. (2015) · Rare Diseases · doi:10.1080/21675511.2015.1012978 · Cited by 8
“PNAS 2014; 111:E538392; PMID:25453094; http://dx.doi.org/10.1073/ pnas.1419553111 This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License (http://creativecom mons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and repro…”
InfluentialNew iPSC for old long QT syndrome modeling: Putting the evidence into perspective
Li, G., Cheng, G., Wu, J., Ma, S., & Sun, C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213514000 · Cited by 8
Zhou, Z., Gong, M., Pande, A., Margineanu, A., Lisewski, U., Purfürst, B., Zhu, H., Liang, L., Jia, S., Froehler, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110291 · Cited by 11
“45 As expected, the UC control showed increased firing in the presence of high glucose or chromanol 293B (Figure 3B).”
Heart Muscle Tissue Engineering: Advantages and Challenges in Cardiac Microtissues
Coffee, M., Biswanath, S., Bolesani, E., & Zweigerdt, R. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-33923-4_6 · Cited by 6
Personalized medicine and the role of induced pluripotent stem cells
van der Heyden, M. A. G., & Jonsson, M. K. B. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs242 · Cited by 6
Defining Cardiomyocyte Repolarization Response to Pharmacotherapy in Long‐QT Syndrome Type 3
Ge, N., Li, R., Liu, M., Xia, W., O'Brien, S. T., McInerney, V., Galvin, J., Ward, D., McGorrian, C., O’Brien, T., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034690 · Cited by 6
The role of iPSC research for insight into inherited arrhythmia conditions
Josvai, M. B., Anderson, C. L., & Eckhardt, L. L. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.2005 · Cited by 4
Campbell, K. A., Terzic, A., & Nelson, T. J. (2015) · Regenerative Medicine · doi:10.2217/rme.15.41 · Cited by 5
The role of cells and their derivatives in otorhinolaryngologic diseases treatment
Ou, H., Yang, Q., Zhang, Y., Tang, X., Xiao, M., Li, S., Lei, L., & Xie, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122898 · Cited by 5
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
Pushpan, C. K., & Kumar, S. R. (2024) · Cells · doi:10.3390/cells13171430 · Cited by 6
“Taken together, they proposed that I(Ks) channels were impaired and demonstrated that KCNQ1 1893delC has a dominant negative effect via a trafficking deficiency [68].”
BackgroundThe updated view on induced pluripotent stem cells for cardiovascular precision medicine
Wang, Y., Lei, W., Yang, J., Ni, X., Ye, L., Shen, Z., & Hu, S. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02530-5 · Cited by 5
Human pluripotent stem cell–based cardiovascular disease modeling and drug discovery
Liu, G., Liu, Z., & Cao, N. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02542-1 · Cited by 5
Using induced pluripotent stem cells for drug discovery in arrhythmias
Teles, D., & Fine, B. M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2360420 · Cited by 6
“The slow delayed rectifier potassium current (I Ks ) was reduced with decreased peak and tail current densities as well as altered channel activation and deactivation properties [34,35].”
BackgroundInfluentialRecent Technological Innovations to Promote Cardiovascular Research
Yuasa, S. (2022) · Circulation Journal · doi:10.1253/circj.cj-21-0978 · Cited by 4
Association of the P441L KCNQ1 variant with severity of long QT syndrome and risk of cardiac events
Lu, H., Wen, D., Xiao, H., Dai, M., Xue, Y., Jia, Z., Guo, J., Wu, M., Shen, B. Q., & Zhao, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.922335 · Cited by 4
Nos3−/− iPSCs model concordant signatures of in utero cardiac pathogenesis
Campbell, K. A., Li, X., Biendarra‐Tiegs, S. M., Terzic, A., & Nelson, T. J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.021 · Cited by 4
Cattelan, G., Altomare, C., Gentile, G., Lavdas, A. Α., Frommelt, L. S., Volani, C., Foco, L., Girardi, P., Peducci, E., Gerbolés, A. G., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.034 · Cited by 3
Current Status of Genome Editing in Cardiovascular Medicine
Termglinchan, V., Karakikes, I., Seeger, T., & Wu, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_7 · Cited by 4
Li, G., HE, X., & Sun, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2668 · Cited by 3
“To date, multiple iPSC models of inherited arrhythmias have been established (Table III C P V T , ca t ec ho l a m i n e r g i c po l y m o r ph i c v e n t r i c u l a r t ac hy ca r d i a ; R y R 2 , r y a nod i n e r ece p t o r i s o f o r m 2 ; L Q T , l ong Q T s ynd r o m e ; h E R G , hu m a n e t h e r - à -…”
Role of induced pluripotent stem cells in diagnostic cardiology
Karch, S. B., Fineschi, V., Francia, P., Scopetti, M., Padovano, M., Manetti, F., Santurro, A., Frati, P., & Volpe, M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i5.331 · Cited by 4
Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine
Chi, H., Gao, S., Yang, X.-C., Cai, J., Zhao, W.-S., Sun, H., & Geng, Y. (2015) · Cardiology · doi:10.1159/000381280 · Cited by 5
Advances in Umbilical Cord Blood Therapy: Hematopoietic Stem Cell Transplantation and Beyond
Chow, T., Mueller, S., & Rogers, I. M. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-29149-9_8 · Cited by 3
An Automated Culture System for Maintaining and Differentiating Human-Induced Pluripotent Stem Cells
Bando, K., Yamashita, H., & Hattori, F. (2024) · Journal of Visualized Experiments · doi:10.3791/65672 · Cited by 3
Wijeyeratne, Y. D., & Behr, E. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_10 · Cited by 3
Utility of Human Stem Cells for Drug Discovery
Chintawar, S., Graf, M. R., & Cader, M. Z. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00162 · Cited by 2
Transformation to Inducible Pluripotent Stem Cells
Kodo, K., Ong, S., & Wu, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00020-5 · Cited by 3
Dirschinger, R. J., Dorn, T., & Moretti, A. (2019) · Cardiac and vascular biology · doi:10.1007/978-3-030-27371-2_10 · Cited by 2
Microelectrode Arrays: A Valuable Tool to Analyze Stem Cell-Derived Cardiomyocytes
Kussauer, S., David, R., & Lemcke, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-77052-5_1 · Cited by 3
Stem Cells in Regenerative Medicine: Prospects and Pitfalls
Zehravi, M., Shahid, O., Ghauri, A. K., Ghori, F. F., & Wahid, M. (2017) · National Journal of Health Sciences · doi:10.21089/njhs.23.0116 · Cited by 1
Liu, Z., Lami, B., Ikonomou, L., & Gu, M. (2023) · Seminars in Perinatology · doi:10.1016/j.semperi.2023.151729 · Cited by 1
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Yamakawa, H., & Fukuda, K. (2016) · Stem Cell Investigation · doi:10.21037/sci.2016.11.07 · Cited by 1
Potential therapeutic drugs for COVID-19 risk prolonging QT interval targeting hERG channelPreprint
Zheng, Z., Wu, Y., Qian, D., & Lian, J. (2020) · doi:10.22541/au.159225345.55326997 · Cited by 1
Yuasa, S., Yazawa, M., & Lee, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.831304 · Cited by 1
“There are substantial reports to elucidate the molecular and cellular mechanisms underlying disease onset and/or the pathophysiological process through various disease-specific iPS cell studies (Yazawa et al., 2011; Egashira et al., 2012; Tanaka et al., 2014; Yasutake et al., 2021).”
BackgroundDisease Models for the Genetic Cardiac Diseases
Pekkanen-Mattila, M., Rajala, K., & Aalto‐Setälä, K. (2013) · InTech eBooks · doi:10.5772/55773
Jambi, M. M., Ye, B., Gollob, M. H., & Davis, D. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.178
“, 2012 [306] LQT1-KCNQ1 Dermal Fibroblast Retrovirus OSKM EB CM morphometry Itzhaki et al.”
BackgroundiPS Cells and Cardiomyopathies
Nakahama, H., & Pasquale, E. D. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-18314-5_6
2) Clinical Application of iPS Cells in Cardiovascular Field
Fukuda, K. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.106b
2) Clinical Application of iPS Cells in Cardiovascular Field
Fukuda, K. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2232
Cardiac Arrhythmia Modelling Using iPS Cells
Yuasa, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_4
Kang, H. Y., & Jeung, E. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-33270-3_2
Ahuja, V., Sharma, S., & Kamboj, R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782626787-00124
Functional Assays and Future Perspectives in Derivation of Cardiomyocytes from Stem Cells
Baba, S. (2016) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.32.397
Li, W. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6220
iPS Cell Generation from the Bank of Peripheral Blood from Patients with Congenital Heart Disease
Yuasa, S. (2015) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.31.320
Generation and Application of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Schuldt, A. J. T., Romero‐Tejeda, M., & Burridge, P. W. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_4
“…al. 2013; Ma et al. 2013a; Wen et al. 2015); diabetic cardiomyopathy (Drawnel et al. 2014); familial long QT syndrome type 1 (Moretti et al. 2010; Egashira et al. 2012; Ma et al. 2015), type 2 (Itzhaki et al. 2011; Matsa et al. 2011; Lahti et al. 2012; Matsa et al. 2014; Jouni et al. 2015; Mehta…”
BackgroundYozu, G., Yuasa, S., Tohyama, S., Seki, T., Takemoto, M., Yokote, K., Fukuda, K., & Daida, H. (2018) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.2018.64.jmj17-oa17
Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Towards Personalized Therapeutic Strategies?
Sinnecker, D., & Moretti, A. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_16
3. Pathophysiological Analysis of Hereditary Heart Disease Using iPS Cells
Fukuda, K. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1588
Induced Pluripotent Stem Cells
van Mil, A., Neef, K., Balk, G. M., Buikema, J. W., Sluijter, J. P. G., & Doevendans, P. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_26
Analysis of contractile functions of human iPS-derived cardiomyocytes using motion field imaging
Yamaguchi, M., Sakamoto, K., & Kurokawa, J. (2021) · Folia Pharmacologica Japonica · doi:10.1254/fpj.21022
Christidi, E. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0402336
Induced pluripotent stem cells for modeling of cardiac arrhythmias
Sayed, Z. R. A., Corli, M., Masurkar, N. D., & Hulot, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00002-3
慎介, 湯. (2015) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.23.2_268
清水, 渉. (2017) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.25.1_14
3. Pathophysiological Analysis of Hereditary Heart Disease Using iPS Cells
Fukuda, K. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.84a
疾患 iPS 細胞を用いた遺伝性不整脈モデルの構築と病態解明
慎介, 湯. (2017) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.25.1_61
Follin, B., Caluori, G., Dobrolińska, M. M., Stachura, J., Muzzamil, H., Wojakowski, W., Qayyum, A. A., & Jadczyk, T. (2023) · Springer eBooks · doi:10.1007/978-981-99-0722-9_3
Pan, Z., & Liang, P. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_663 · Cited by 2
Kussauer, S., David, R., & Lemcke, H. (2023) · Springer eBooks · doi:10.1007/978-3-031-25378-2_1
Elucidation of cardiovascular disease mechanisms and development of innovative therapies
Yuasa, S. (2024) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.136.12
Paavola, K. (2015) · Tampere University Institutional Repository (Tampere University)
Metadata
- Authors
- Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T., Ohno, Y., Tohyama, S., Okata, S., Seki, T., Kuroda, Y., Yae, K., Hashimoto, H., Tanaka, T., Hattori, F., Sato, T., Miyoshi, S., Takatsuki, S., Murata, M., Kurokawa, J., Furukawa, T., Makita, N., Aiba, T., Shimizu, W., Horie, M., Kamiya, K., Kodama, I., Ogawa, S., & Fukuda, K.
- Affiliations
- Keio University (JP)
- Tokyo Medical and Dental University (JP)
- Nagasaki University (JP)
- National Cerebral and Cardiovascular Center (JP)
- Shiga University of Medical Science (JP)
- Research Institute of Environmental Medicine, Nagoya University (JP)
- Corresponding author
- Yuasa, Shinsuke
- Fukuda, Keiichi
- ORCID
- Yuasa, Shinsuke
- Suzuki, Tomoyuki
- Aizawa, Yoshiyasu
- Yamakawa, Hiroyuki
- Matsuhashi, Tomohiro
- Ohno, Yohei
- Tohyama, Shugo
- Seki, Tomohisa
- Kuroda, Yusuke
- Yae, Kojiro
- Hashimoto, Hisayuki
- Tanaka, Tomofumi
- Hattori, Fumiyuki
- Sato, Toshiaki
- Takatsuki, Seiji
- Murata, Mitsushige
- Kurokawa, Junko
- Furukawa, Tetsushi
- Makita, Naomasa
- Aiba, Takeshi
- Shimizu, Wataru
- Horie, Minoru
- Ogawa, Satoshi
- Fukuda, Keiichi
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-27
- Volume
- 95
- Issue
- 4
- Pages
- 419-429
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2133808555
- Cited by
- 178
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 16 · 2020: 11 · 2019: 5 · 2018: 12 · 2017: 19 · 2016: 23 · 2015: 29 · 2014: 16 · 2013: 17 · 2012: 5
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22590779, 22590813, 23590297, 22689027, 24591086, 23790873, 24390199)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome, induced pluripotent stem cells, iPSC-derived cardiomyocytes, embryoid body differentiation, field potential duration, IKs channel, dominant negative effect, ion channel trafficking, E-4031, chromanol 293B, cardiac arrhythmias, personalized medicine, novel mutations
- MeSH terms
- Action Potentials, Adolescent, Animals, Cell Differentiation, Fluorescent Antibody Technique, Humans, Male, Phenotype, Teratoma, Time Factors, Transfection, Patch-Clamp Techniques, Gene Expression Regulation, Developmental, Coculture Techniques, Genetic Predisposition to Disease, Potassium Channels, Voltage-Gated, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, Mice, KCNQ1 Potassium Channel, Intermediate-Conductance Calcium-Activated Potassium Channels, Induced Pluripotent Stem Cells, HEK293 Cells, Embryoid Bodies, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.